Baker Ellis Asset Management’s Eli Lilly LLY Stock Holding History

Baker Ellis Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.25M	Buy	3,547 +2	+0.1%	+$2.04K	0.44%	56
2026 Q1	$3.26M	Buy	3,545 +9	+0.3%	+$9.12K	0.39%	67
2025 Q4	$3.8M	Buy	3,536 +75	+2%	+$71.7K	0.46%	55
2025 Q3	$2.64M	Buy	3,461 +3,061	+765%	+$2.28M	0.33%	72
2025 Q2	$312K	Hold	400	–	–	0.04%	182
2025 Q1	$330K	Sell	400 -30	-7%	-$25K	0.05%	178
2024 Q4	$332K	Buy	430 +30	+8%	+$24.8K	0.05%	170
2024 Q3	$354K	Hold	400	–	–	0.05%	172
2024 Q2	$362K	Sell	400 -35	-8%	-$28K	0.05%	161
2024 Q1	$338K	Buy	435 +35	+9%	+$24.9K	0.05%	167
2023 Q4	$233K	Hold	400	–	–	0.04%	191
2023 Q3	$215K	Buy	+400	New	+$206K	0.04%	192
2017 Q2	–	Sell	-1,700	Closed	-$143K	–	243
2017 Q1	$143K	Hold	1,700	–	–	0.04%	214
2016 Q4	$125K	Buy	+1,700	New	+$127K	0.04%	221

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Baker Ellis Asset Management's LLY Position: Q2 2026 in Review

Baker Ellis Asset Management increased its Eli Lilly (LLY) stake by 0.06% in Q2 2026, buying an estimated $2.04K and bringing the position to 3,547 shares worth $4.25M. The position accounts for 0.44% of the portfolio, ranked #56.

Baker Ellis Asset Management first reported a position in LLY in Q4 2016 and has held it in 14 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Baker Ellis Asset Management held 3,547 shares of Eli Lilly worth $4.25M as of Q2 2026.
Baker Ellis Asset Management bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
Eli Lilly made up 0.44% of Baker Ellis Asset Management's portfolio in Q2 2026, its #56 holding.
Baker Ellis Asset Management first reported a position in Eli Lilly in Q4 2016 and has held it in 14 quarters since.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Baker Ellis Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.